1. Home
  2. TKNO vs SVII Comparison

TKNO vs SVII Comparison

Compare TKNO & SVII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKNO
  • SVII
  • Stock Information
  • Founded
  • TKNO 1996
  • SVII 2021
  • Country
  • TKNO United States
  • SVII United States
  • Employees
  • TKNO N/A
  • SVII N/A
  • Industry
  • TKNO Medicinal Chemicals and Botanical Products
  • SVII Blank Checks
  • Sector
  • TKNO Health Care
  • SVII Finance
  • Exchange
  • TKNO Nasdaq
  • SVII Nasdaq
  • Market Cap
  • TKNO 356.4M
  • SVII 116.6M
  • IPO Year
  • TKNO 2021
  • SVII 2022
  • Fundamental
  • Price
  • TKNO $5.06
  • SVII $11.75
  • Analyst Decision
  • TKNO Buy
  • SVII
  • Analyst Count
  • TKNO 1
  • SVII 0
  • Target Price
  • TKNO $5.00
  • SVII N/A
  • AVG Volume (30 Days)
  • TKNO 330.7K
  • SVII 5.0K
  • Earning Date
  • TKNO 08-12-2025
  • SVII 01-01-0001
  • Dividend Yield
  • TKNO N/A
  • SVII N/A
  • EPS Growth
  • TKNO N/A
  • SVII N/A
  • EPS
  • TKNO N/A
  • SVII 0.25
  • Revenue
  • TKNO $38,250,000.00
  • SVII N/A
  • Revenue This Year
  • TKNO $8.73
  • SVII N/A
  • Revenue Next Year
  • TKNO $16.53
  • SVII N/A
  • P/E Ratio
  • TKNO N/A
  • SVII $47.30
  • Revenue Growth
  • TKNO 3.79
  • SVII N/A
  • 52 Week Low
  • TKNO $1.16
  • SVII $11.06
  • 52 Week High
  • TKNO $10.37
  • SVII $11.90
  • Technical
  • Relative Strength Index (RSI)
  • TKNO 32.47
  • SVII 54.77
  • Support Level
  • TKNO $4.72
  • SVII $11.50
  • Resistance Level
  • TKNO $5.65
  • SVII $11.78
  • Average True Range (ATR)
  • TKNO 0.35
  • SVII 0.08
  • MACD
  • TKNO -0.05
  • SVII -0.00
  • Stochastic Oscillator
  • TKNO 27.37
  • SVII 78.86

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

About SVII Spring Valley Acquisition Corp. II

Spring Valley Acquisition Corp II is a blank check company.

Share on Social Networks: